CN103830616A - 治疗猪瘟的中药及其制备方法 - Google Patents
治疗猪瘟的中药及其制备方法 Download PDFInfo
- Publication number
- CN103830616A CN103830616A CN201410039402.2A CN201410039402A CN103830616A CN 103830616 A CN103830616 A CN 103830616A CN 201410039402 A CN201410039402 A CN 201410039402A CN 103830616 A CN103830616 A CN 103830616A
- Authority
- CN
- China
- Prior art keywords
- grams
- herba
- radix
- chinese medicine
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 75
- 241000282898 Sus scrofa Species 0.000 title claims abstract description 68
- 206010037660 Pyrexia Diseases 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 235000009815 Momordica Nutrition 0.000 claims abstract description 45
- 241000218984 Momordica Species 0.000 claims abstract description 45
- 230000001954 sterilising effect Effects 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 6
- 238000004140 cleaning Methods 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 241000628997 Flos Species 0.000 claims description 51
- 210000000582 semen Anatomy 0.000 claims description 51
- 241000237636 Pheretima Species 0.000 claims description 50
- 239000010231 banlangen Substances 0.000 claims description 50
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 49
- 235000005903 Dioscorea Nutrition 0.000 claims description 44
- 241000234273 Dioscorea Species 0.000 claims description 44
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 44
- 241001530126 Scrophularia Species 0.000 claims description 44
- 241000207929 Scutellaria Species 0.000 claims description 44
- 235000004879 dioscorea Nutrition 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000003304 gavage Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 239000010414 supernatant solution Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 241000555682 Forsythia x intermedia Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 26
- 230000001154 acute effect Effects 0.000 abstract description 19
- 230000001684 chronic effect Effects 0.000 abstract description 13
- 206010011224 Cough Diseases 0.000 abstract description 12
- 230000006870 function Effects 0.000 abstract description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 9
- 241000700605 Viruses Species 0.000 abstract description 9
- 208000026435 phlegm Diseases 0.000 abstract description 9
- 208000004232 Enteritis Diseases 0.000 abstract description 8
- 206010035664 Pneumonia Diseases 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 8
- 206010010741 Conjunctivitis Diseases 0.000 abstract description 7
- 241000282887 Suidae Species 0.000 abstract description 7
- 208000006673 asthma Diseases 0.000 abstract description 6
- 206010044008 tonsillitis Diseases 0.000 abstract description 4
- 230000000840 anti-viral effect Effects 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000001405 Artemisia annua Nutrition 0.000 abstract 1
- 240000000011 Artemisia annua Species 0.000 abstract 1
- 241000596154 Belamcanda Species 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 235000014676 Phragmites communis Nutrition 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000003582 Platycodon grandiflorus Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 238000007598 dipping method Methods 0.000 abstract 1
- 235000015277 pork Nutrition 0.000 abstract 1
- 230000001850 reproductive effect Effects 0.000 abstract 1
- 241000555712 Forsythia Species 0.000 description 43
- 241000245240 Lonicera Species 0.000 description 42
- 208000024891 symptom Diseases 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 13
- 230000000844 anti-bacterial effect Effects 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 11
- 241000710777 Classical swine fever virus Species 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 239000003440 toxic substance Substances 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 230000002159 abnormal effect Effects 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 208000006454 hepatitis Diseases 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 208000003322 Coinfection Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010068319 Oropharyngeal pain Diseases 0.000 description 5
- 201000007100 Pharyngitis Diseases 0.000 description 5
- 206010057190 Respiratory tract infections Diseases 0.000 description 5
- 208000033809 Suppuration Diseases 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 230000001754 anti-pyretic effect Effects 0.000 description 5
- 239000002221 antipyretic Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 231100000283 hepatitis Toxicity 0.000 description 5
- 201000003453 lung abscess Diseases 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 4
- 206010052369 Encephalitis lethargica Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 208000022531 anorexia Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000000994 depressogenic effect Effects 0.000 description 4
- 239000003640 drug residue Substances 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 201000002498 viral encephalitis Diseases 0.000 description 4
- 230000001018 virulence Effects 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010003011 Appendicitis Diseases 0.000 description 3
- 208000004429 Bacillary Dysentery Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 241000282894 Sus scrofa domesticus Species 0.000 description 3
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 201000005113 shigellosis Diseases 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010008631 Cholera Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 206010001093 acute tonsillitis Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- -1 luteolin glycosides Chemical class 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010062343 Congenital infection Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010048612 Hydrothorax Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 208000001300 Perinatal Death Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241000710778 Pestivirus Species 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000006257 Rinderpest Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000193395 Sporosarcina pasteurii Species 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 229940031567 attenuated vaccine Drugs 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 231100000429 cutaneous necrosis Toxicity 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229940001501 fibrinolysin Drugs 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000000590 parasiticidal effect Effects 0.000 description 1
- 239000002297 parasiticide Substances 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000015339 staphylococcus aureus infection Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Abstract
Description
患病类型 | 治疗总数 | 痊愈例数 | 有效例数 | 无效例数 | 有效率 |
急性/亚急性 | 865 | 834 | 19 | 12 | 98.61% |
慢性型 | 658 | 624 | 26 | 8 | 98.78% |
合计 | 1523 | 1458 | 45 | 20 | 98.69% |
分组 | 出生总数 | 死亡头数 | 死亡率 | 正常头数 | 异常头数 | 异常率 |
实验组 | 956 | 42 | 4.39% | 882 | 74 | 7.74% |
对照组 | 723 | 197 | 27.25% | 519 | 204 | 28.22% |
分组 | 总头数 | 继发感染肺炎头数 | 继发感染肠炎头数 | 其它继发感染头数 | 一周死亡头数 | 周死亡率 |
实验组 | 500 | 16 | 23 | 9 | 14 | 2.8% |
对照组 | 500 | 83 | 56 | 24 | 78 | 15.6% |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410039402.2A CN103830616B (zh) | 2014-01-27 | 2014-01-27 | 治疗猪瘟的中药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410039402.2A CN103830616B (zh) | 2014-01-27 | 2014-01-27 | 治疗猪瘟的中药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103830616A true CN103830616A (zh) | 2014-06-04 |
CN103830616B CN103830616B (zh) | 2017-05-03 |
Family
ID=50794718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410039402.2A Active CN103830616B (zh) | 2014-01-27 | 2014-01-27 | 治疗猪瘟的中药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103830616B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104258139A (zh) * | 2014-09-28 | 2015-01-07 | 山东新希望六和集团有限公司 | 一种用于防治慢性型猪瘟疫的药物组合物及其制备方法 |
CN105661069A (zh) * | 2016-01-22 | 2016-06-15 | 广州暨南生物医药研究开发基地有限公司 | 一种改善猪繁殖性能的饲料添加剂及其制备方法 |
CN105982995A (zh) * | 2016-01-28 | 2016-10-05 | 宿州瑞泰农业发展有限公司 | 一种治疗慢性猪瘟的特效中兽药口服液 |
CN108142683A (zh) * | 2016-12-03 | 2018-06-12 | 灵丘县动物疫病预防控制中心 | 一种猪肺疫防疫饲料及制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102771631A (zh) * | 2012-06-30 | 2012-11-14 | 王志坚 | 防治猪瘟的中药饲料添加剂 |
CN103211997A (zh) * | 2013-05-13 | 2013-07-24 | 刘健享 | 一种抗菌抗病毒的中药组合物法及其制备方法 |
CN103251789A (zh) * | 2013-05-10 | 2013-08-21 | 曾舟 | 治疗猪瘟的中药剂 |
-
2014
- 2014-01-27 CN CN201410039402.2A patent/CN103830616B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102771631A (zh) * | 2012-06-30 | 2012-11-14 | 王志坚 | 防治猪瘟的中药饲料添加剂 |
CN103251789A (zh) * | 2013-05-10 | 2013-08-21 | 曾舟 | 治疗猪瘟的中药剂 |
CN103211997A (zh) * | 2013-05-13 | 2013-07-24 | 刘健享 | 一种抗菌抗病毒的中药组合物法及其制备方法 |
Non-Patent Citations (1)
Title |
---|
陈茂存: "慢性猪瘟与温和型猪瘟的中兽医论治", 《中兽医学杂志》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104258139A (zh) * | 2014-09-28 | 2015-01-07 | 山东新希望六和集团有限公司 | 一种用于防治慢性型猪瘟疫的药物组合物及其制备方法 |
CN105661069A (zh) * | 2016-01-22 | 2016-06-15 | 广州暨南生物医药研究开发基地有限公司 | 一种改善猪繁殖性能的饲料添加剂及其制备方法 |
CN105982995A (zh) * | 2016-01-28 | 2016-10-05 | 宿州瑞泰农业发展有限公司 | 一种治疗慢性猪瘟的特效中兽药口服液 |
CN108142683A (zh) * | 2016-12-03 | 2018-06-12 | 灵丘县动物疫病预防控制中心 | 一种猪肺疫防疫饲料及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103830616B (zh) | 2017-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103816361A (zh) | 预防治疗禽流感的中药及其制备方法 | |
CN103830616A (zh) | 治疗猪瘟的中药及其制备方法 | |
CN103721103B (zh) | 用于治疗猪丹毒的药物及其制备方法 | |
CN104800660A (zh) | 一种治疗肺炎支原体肺炎的中药制剂及其制备方法 | |
CN102526510B (zh) | 一种用于预防和治疗鸭病毒性肝炎的中药组合物 | |
CN104117005A (zh) | 一种治疗热射病的中药制剂及其制备方法 | |
CN104208393A (zh) | 一种用于防治鸡传染性支气管炎的中药组合物及其制备方法 | |
CN103520530B (zh) | 一种治疗丹毒的药物及其制备方法 | |
CN104906465A (zh) | 一种治疗妇女慢性盆腔炎的中药化瘀组合物及其制备方法 | |
CN103751509B (zh) | 一种治疗临床型乳房炎的中草药组合物 | |
CN105169318A (zh) | 一种治疗银龙鱼白点病的中草药制剂及其制备方法 | |
CN104524302A (zh) | 一种治疗热毒郁络型硬皮病的中药组合物 | |
CN108310135A (zh) | 一种防治鸡大肠杆菌病的饲料添加剂 | |
CN103610915A (zh) | 一种治疗咽喉肿痛的中药 | |
CN103505539A (zh) | 一种治疗烫伤的中草药配方 | |
CN108208402A (zh) | 一种猪饲料的中药添加剂 | |
CN102657772B (zh) | 用于治疗鸡葡萄球菌病的煎剂、饲料和制备方法 | |
CN103341151B (zh) | 用于治疗慢性支气管炎的中药 | |
CN106344876A (zh) | 一种防治畜禽呼吸道疾病的中药组合物及其制备方法 | |
CN106310049A (zh) | 一种治疗肛肠疾病的中药颗粒剂及其制备方法 | |
CN105661053A (zh) | 一种植物性羊饲料添加剂 | |
CN104547581A (zh) | 风湿性腰椎病疏风散寒药酒及制备方法 | |
CN104306832A (zh) | 一种治疗邪毒犯心型病毒性心肌炎的中药制剂及其制备方法 | |
CN104189451A (zh) | 化脓型败血症清热解毒汤及制备方法 | |
CN103623192A (zh) | 用于治疗猪蓝耳病的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A traditional Chinese medicine for treating swine fever and a preparation method thereof Effective date of registration: 20200313 Granted publication date: 20170503 Pledgee: Bank of China Limited by Share Ltd. Zhecheng branch Pledgor: HENAN ZHONGSHENG ANIMAL PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980000698 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210415 Granted publication date: 20170503 Pledgee: Bank of China Limited by Share Ltd. Zhecheng branch Pledgor: HENAN ZHONGSHENG ANIMAL PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980000698 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicine for classical swine fever and its preparation Effective date of registration: 20210420 Granted publication date: 20170503 Pledgee: Bank of China Limited by Share Ltd. Zhecheng branch Pledgor: HENAN ZHONGSHENG ANIMAL PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980002807 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CP03 | Change of name, title or address |
Address after: No. 6 Danyang Avenue, East District, Industrial Cluster District, Zhecheng County, Shangqiu City, Henan Province, 476000 Patentee after: Henan Zhongsheng Bioengineering Co.,Ltd. Address before: No. 19, 8th Floor, Building B, Rongyuan Square, North Section of Huayuan Road, Zhengzhou City, Henan Province, 450000 Patentee before: HENAN ZHONGSHENG ANIMAL PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230809 Granted publication date: 20170503 Pledgee: Bank of China Limited by Share Ltd. Zhecheng branch Pledgor: HENAN ZHONGSHENG ANIMAL PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980002807 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese Medicine and Its Preparation Method for Treating Swine Fever Effective date of registration: 20230811 Granted publication date: 20170503 Pledgee: Bank of China Limited by Share Ltd. Zhecheng branch Pledgor: Henan Zhongsheng Bioengineering Co.,Ltd. Registration number: Y2023980051698 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |